Corning to receive $204 million funding to tackle Covid-19

Published 10th June, 2020 by Greg Morris

Pharmaceutical glassmaker Corning Incorporated will receive $204 million from the US government to expand the manufacturing capacity of its Valor glass vials used to store coronavirus vaccines and treatments.

The investment will enable Corning to increase the manufacturing capabilities of its three US facilities in Big Flats, New York; Durham, North Carolina; and Vineland, New Jersey.

The increase in vial manufacturing surge capacity will help meet the rapidly growing demand for glass containers as pharmaceutical companies enter Covid-19 clinical trials towards eventual approval of vaccines and treatments.

Wendell P. Weeks, Corning’s chairman and chief executive officer, said: “Corning is ready to do our part in the fight against the pandemic, as well as to help prepare for future public health emergencies.”

Greg Morris

Glass International Editor

Greg Morris has been editor of Glass International and organiser of the Glassman conferences since 2012, specialising in glass packaging. Prior to this he spent five years working in newspaper journalism.